Recent Articles from StockStory

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflected growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

Specialty insurance provider Fidelis Insurance (NYSE:FIHL) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 5% year on year to $651.9 million. Its non-GAAP profit of $1.21 per share was 1% above analysts’ consensus estimates.

Cash-back rewards platform Ibotta (NYSE:IBTA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 15.6% year on year to $83.26 million. On the other hand, next quarter’s revenue guidance of $82.5 million was less impressive, coming in 1.9% below analysts’ estimates. Its GAAP profit of $0.05 per share was significantly above analysts’ consensus estimates.

Networking technology giant Cisco (NASDAQ:CSCO) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 7.5% year on year to $14.88 billion. Guidance for next quarter’s revenue was optimistic at $15.1 billion at the midpoint, 3% above analysts’ estimates. Its non-GAAP profit of $1 per share was 1.9% above analysts’ consensus estimates.

Digital storytelling platform WEBTOON (NASDAQ:WBTN) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 8.7% year on year to $378 million. Next quarter’s revenue guidance of $335 million underwhelmed, coming in 15.8% below analysts’ estimates. Its GAAP loss of $0.09 per share was 23.9% above analysts’ consensus estimates.

Environmental engineering firm Tetra Tech (NASDAQ:TTEK) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 7.7% year on year to $1.23 billion. The company expects next quarter’s revenue to be around $975 million, close to analysts’ estimates. Its GAAP profit of $0.48 per share was 18.5% above analysts’ consensus estimates.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflected growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflected growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. 

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflected growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflected growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. 

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflected growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflected growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflected growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflects growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, which were perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflects growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, which were perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 3.9% in the afternoon session after the stock's positive momentum continued as the company reported impressive financial results for the third quarter of 2025, showing resilient performance and robust sales growth. In its earnings report from the previous day, the company disclosed net revenues of $191.8 million for the quarter. Furthermore, its adjusted net income reached $44.7 million, which translated to $0.93 per diluted share. This performance underscored the company's strong financial health, even as it navigated challenges like increased competition and sales declines in certain product areas. The positive results appeared to give investors confidence in the company's standing.

Shares of environmental waste treatment and services provider Perma-Fix (NASDAQ:PESI) fell 10.8% in the afternoon session after the company reported third-quarter results that revealed a significant revenue decline in its Services segment. That segment's revenue fell to $4.3 million from $7.7 million in the same period of the previous year. The company stated this drop was mainly due to delays in Department of Energy and Department of Defense projects, along with slower timing for new awards. Adding to investor concerns, Perma-Fix noted that its expansion into the PFAS market was progressing slower than initially hoped. The company also reported a non-GAAP loss of $0.10 per share during the quarter. These challenges appeared to outweigh positive results in other areas, such as the Treatment segment.

Shares of infrastructure investment and operations firm FTAI Infrastructure (NASDAQ:FIP) fell 6% in the afternoon session after the stock's negative momentum continued as the company reported disappointing third-quarter 2025 financial results, missing analyst expectations for both revenue and earnings. The company's revenue for the quarter was $140.6 million, falling short of the $146.4 million analysts had forecast. The earnings miss was more significant, with a reported loss per share of $1.38, which was much wider than the estimated loss of $0.59 per share. Overall, the net loss attributable to stockholders widened to $118.4 million. The company pointed to higher expenses, integration costs, and increased interest expense as reasons for the larger loss. Additionally, the company's financial health showed other signs of strain, as its operating margin fell sharply to -70.8% from -5.3% in the same period of the previous year, and its free cash flow was a negative $90.71 million.

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) fell 7.5% in the afternoon session after the market continued to react negatively to the company's third-quarter financial results, which missed Wall Street expectations. Management pointed to a slowdown in instrument shipments, especially its Vega systems in Europe, and lower average selling prices for its Revio systems as the main reasons for the underperformance. The company's CEO also described the funding environment in the Americas as “challenging,” which made it take longer for some academic and government research customers to make purchases. Adding to investor concerns, the company is not yet profitable and reported a net loss of $38 million in the last quarter.

Shares of healthcare data analytics company Health Catalyst (NASDAQ:HCAT) fell 7.3% in the afternoon session after its third-quarter earnings report revealed a weak financial outlook, which prompted a lower price target from analysts. Although the healthcare data analytics company beat Wall Street's revenue expectations, sales were flat compared to the previous year. More importantly, the company's revenue guidance for the next quarter came in below analysts' estimates, and its forecast for 2026 suggested a continued sales decline. Investors were concerned by several headwinds facing the company, including challenges in migrating clients to a lower-cost platform and pressure on customer retention. The company's professional services revenue also fell, and its cash reserves saw a significant decrease. In response to the weak outlook, analysts at Stifel lowered their price target on the stock, and other analysts also revised their earnings estimates downward.

Shares of healthcare solutions company Evolent Health (NYSE:EVH) fell 10.3% in the afternoon session after Oppenheimer significantly lowered its price target on the stock. The investment firm cut its view on the stock's future price from $18.00 to $12.00, a notable 33.33% reduction. The substantial cut in the price target likely raised concerns among investors about the company's near-term prospects, contributing to the stock's decline.

Shares of luxury electric car manufacturer Lucid (NASDAQ:LCID) fell 5% in the afternoon session after the company announced the pricing of an $875 million offering of convertible senior notes. The notes, due in 2031, are a form of debt that can be turned into company stock. This news often worries investors because if the notes are converted, it could increase the number of shares and lessen the value of existing ones. The company also gave the initial buyers an option to purchase up to an additional $100 million in notes. Lucid stated that it planned to use most of the proceeds, about $752 million, to repurchase older convertible notes that were due in 2026. The rest of the funds were intended for general corporate purposes, effectively extending the company's debt maturity.

Shares of healthcare apparel company Figs (NYSE:FIGS) jumped 5.7% in the afternoon session after several analysts raised their price targets for the company. 

Shares of online study and academic help platform Chegg (NYSE:CHGG) jumped 5.3% in the afternoon session after the company reported third-quarter results that showed better-than-expected profitability and a strategic shift toward its growing skilling business, overshadowing a steep drop in overall revenue. Total revenue fell by 42% year-over-year to $78 million, but the company surpassed its adjusted EBITDA guidance by $5 million due to cost-cutting efforts. Chegg announced it was restructuring into two units, with a focus on its "Chegg Skilling" division as the new growth engine. This segment, which includes professional courses, was on track for 14% year-over-year growth with a projected full-year revenue of $70 million. The company also announced the return of Dan Rosensweig as CEO to lead this strategic pivot. Investors appeared to focus on the company's improved operational management and the growth potential in the skilling market rather than the decline in its traditional academic services.

Shares of lifting and material handling equipment company Terex (NYSE:TEX) jumped 3% in the morning session after analysts raised their price target on the stock, pointing to a better earnings outlook and positive trends in the heavy equipment sector. The price target was increased to $59.70 from $56.82. Analysts noted that an improved business mix and less volatile earnings boosted their confidence in the company. This view was bolstered by projections for the broader North American Heavy Construction Equipment Market, which was expected to grow, driven by government investment in infrastructure. The stock's advance marked a reversal, as it followed a five-day period of declines.

Shares of solar tracker company Nextracker (NASDAQ:NXT) fell 8.5% in the morning session after the company announced a corporate rebranding to Nextpower and provided long-term financial targets during its Capital Markets Day. The move reflected the company's expansion from a solar tracking systems provider into an integrated energy technology platform. As part of the shift, the company also announced the development of a power conversion product line, with first shipments expected in 2026. During the event, Nextpower outlined a revenue target of $4.8 billion to $5.6 billion by fiscal year 2030. While the company reaffirmed its fiscal 2026 outlook and provided a new forecast for fiscal 2027, the stock's decline suggested investor expected more given the stock's rally since the start of the year.

Shares of technology and consulting giant IBM (NYSE:IBM) jumped 2% in the morning session after the company announced significant breakthroughs in its quantum computing division, including the unveiling of its most advanced processor yet, the IBM Quantum Nighthawk. The technology giant detailed its progress at its annual Quantum Developer Conference, stating that the new processor kept it on track to deliver "quantum advantage" — the point at which a quantum computer can solve a problem better than any classical computer. The company also announced the Quantum Loon, a test chip that included all the necessary components for building large-scale, advanced quantum computers. IBM noted that the Nighthawk processor could execute circuits with 30% more complexity and was about 30% more efficient than its predecessor. This news was met with enthusiasm from investors, who saw the announcements as a key step toward unlocking a multi-billion dollar revenue potential for IBM's quantum business in the long term.

Shares of leading data storage manufacturer Western Digital (NASDAQ: WDC) fell 2.1% in the morning session as markets continued to scrutinize lofty AI valuations amid a rotation out of tech names. Also, the company announced a new range of data storage products for the Australian market. The new offerings were intended to appeal to a wide variety of users, from creators and gamers to professionals. These products featured large capacities and rugged designs for reliable storage. The stock's reaction suggested markets expected more.

Shares of beauty and waxing service franchise European Wax Center (NASDAQ:EWCZ) jumped 15.8% in the morning session after the company reported third-quarter 2025 financial results that surpassed Wall Street's expectations on profit and revenue. Although revenue declined 2.2% year on year to $54.2 million, the figure still topped analysts' forecasts. The company's profitability was a key highlight for the quarter. GAAP earnings per share of $0.09 was more than double the consensus estimate of $0.04. Furthermore, adjusted EBITDA, a key measure of profitability, came in at $20.2 million, handily beating expectations of $15.7 million. While the company reaffirmed its full-year revenue outlook, its full-year EBITDA guidance was slightly below analysts' projections. Overall, the strong bottom-line performance appeared to outweigh the mixed guidance, driving investor optimism.

Shares of freight Delivery Company RXO (NYSE:RXO) jumped 6.2% in the morning session after Morgan Stanley upgraded the stock's rating from Equal-Weight to Overweight and set a new price target of $19.00. The upgrade from analyst Ravi Shanker provided a positive signal for investors. This action followed a notable insider purchase just a few days prior, where director Thomas A. Szlosek acquired over 20,000 shares for a total of approximately $251,209. Such a purchase often indicates strong confidence from company leadership. The positive sentiment from the upgrade and insider activity seemed to overshadow the company's recent third-quarter results, in which its earnings before certain costs were below expectations.

Shares of telecom software provider Amdocs (NASDAQ:DOX) fell 6.2% in the morning session after the company's third-quarter earnings report pointed to a weaker profit outlook. The company's revenue for the third quarter of 2025 came in at $1.15 billion, a 9% decline year-over-year, though it slightly beat Wall Street's expectations. Adjusted earnings per share of $1.83 were in line with analyst consensus. However, investors were more concerned with the company's forecast. While Amdocs guided for fourth-quarter revenue that was slightly ahead of estimates, its adjusted earnings per share guidance of $1.76 at the midpoint fell short of the $1.87 analysts were expecting. This weaker profit forecast signaled potential pressure on profitability, overshadowing the modest revenue beat and prompting a negative reaction from the market.

Shares of power conversion and control solutions provider Vicor Corporation (NASDAQ:VICR) jumped 2.7% in the morning session after investor optimism continued following the company's blowout third-quarter financial results. The company shattered analyst expectations, reporting earnings of $0.63 per share, which was a staggering 142% increase compared to the previous year and well above the forecasted $0.12 to $0.17. Revenue also beat estimates, coming in at $110.4 million. The strong performance was credited to growing demand from AI data centers, which require the kind of high-density power systems that Vicor designs. The positive earnings, first announced in late October, fueled a significant surge in the stock, which has now reached a 52-week high.

Shares of civil infrastructure construction company Sterling Infrastructure (NASDAQ:STRL) rose in the morning session after its Board of Directors authorized a new $400 million stock repurchase program. The new program, set to run over 24 months, replaced a previous plan that had $81 million in remaining capacity. Stock buybacks can signal that a company's leadership believes its own shares are a good investment, which often boosts investor confidence. Sterling's CEO, Joe Cutillo, stated that the move reflected the company's "continued confidence in Sterling's outlook," pointing to its strong balance sheet and cash flow. This financial health was highlighted in the company's recent third-quarter results, where both earnings and revenues grew significantly and beat expectations. The company also reported a record backlog of $2.6 billion, suggesting solid demand for its services.

Shares of home energy technology company Enphase (NASDAQ:ENPH) rose in the morning session after it announced a new partnership with Green Mountain Power (GMP) to launch a home battery lease program in Vermont. The partnership involved Green Mountain Power selecting Enphase to join its home battery lease program. Under the agreement, eligible customers in Vermont were offered a ten-year lease on two IQ Battery 10C systems for $55 per month or a single payment of $5,500. This arrangement provided customers with backup power while also allowing them to share stored energy during peak times. This shared energy supported GMP's 75 MW virtual power plant, the largest of its kind in Vermont, helping to lower costs for all customers and improve grid stability. Enphase also noted a planned 2026 launch for a new bidirectional EV charger.

Shares of buy now, pay later company Affirm (NASDAQ:AFRM) jumped 3% in the morning session after the stock's positive momentum continued as the company reported strong first-quarter fiscal 2026 financial results that surpassed expectations. The buy now, pay later firm announced earnings of 23 cents per share, which easily beat analyst estimates. This result was a significant improvement from the loss of 31 cents per share reported in the same quarter of the previous year. Total revenues grew by 33.6% year over year to $933.3 million, also coming in ahead of the company's own forecast. The strong performance was fueled by a 42% jump in Gross Merchandise Value to $10.8 billion. Affirm also saw its active merchant count climb 30% to 419,000, as transaction volumes increased. For the upcoming quarter, the company guided for revenues between $1.03 billion and $1.06 billion.

Shares of aerospace and defense company Rocket Lab (NASDAQ:RKLB) fell 0.3% in the morning session after the company reported better-than-expected third-quarter results and provided strong fourth-quarter revenue guidance, which prompted positive actions from multiple analysts. The space company posted record third-quarter revenue of $155.08 million, a 48% increase from the same period in the previous year. Looking ahead, Rocket Lab also gave an upbeat forecast for fourth-quarter revenue between $170 million and $180 million, which boosted investor confidence. In response to the news, several investment firms reiterated their positive views. An analyst at Stifel Nicolaus raised the price target on the stock to $75 from $65. Similarly, Needham increased its price target to $63 from $55, while KeyBanc Capital Markets maintained its Overweight rating and $75 price target.

Shares of government engineering solutions provider Amentum Holdings (NYSE:AMTM) jumped 2% in the morning session after it was awarded a contract by the U.S. Air Force Air Combat Command with a ceiling value of up to $995 million. 

Shares of ride sharing service Lyft (NASDAQ: LYFT) jumped 1.2% in the morning session after several analysts raised their price targets on the stock, signaling renewed confidence following its recent earnings report. This optimism was reflected in specific actions, as research firm Sanford C. Bernstein increased its price objective on the ride-sharing company's stock to $23.00 from $22.00. Another firm, Canaccord, also recently lifted its target to $19. These positive revisions came after Lyft's latest quarterly earnings results, which were released earlier in the month.

Shares of fantasy sports and betting company DraftKings (NASDAQ:DKNG) jumped 1.9% in the morning session after a company director, Harry Sloan, disclosed a significant purchase of company stock valued at $757,500. The transaction involved 25,000 shares bought at a weighted average price of $30.30. Such a substantial purchase by an insider was often viewed by investors as a signal of confidence in the company's future prospects. Following the purchase, Sloan's direct ownership in DraftKings increased to 249,712 shares. Adding to the positive sentiment, analysts at Stifel Nicolaus reiterated their "buy" rating on the stock. However, the firm did lower its price objective to $46.00 from a previous target of $50.00.

Shares of online used car dealer Carvana (NYSE: CVNA) jumped 2.1% in the morning session after Barclays initiated coverage on the stock with an 'Overweight' rating and a $390 price target. 

Shares of luxury fashion conglomerate Tapestry (NYSE:TPR) jumped 1.8% in the morning session after the company appointed a new executive to lead its data and artificial intelligence initiatives. 

Shares of e-commerce and gaming company Sea (NYSE:SE) jumped 2.2% in the morning session after Deutsche Bank upgraded the stock from 'Hold' to 'Buy', and the company posted strong third-quarter financial results. 

Shares of casual restaurant chain Brinker International (NYSE:EAT) jumped 6.1% in the morning session after investors focused on the company's previously reported upbeat quarterly earnings from late October. 

Shares of packaged food company Simply Good Foods (NASDAQ:SMPL) jumped 3% in the morning session after an analyst at Mizuho maintained an 'Outperform' rating on the stock and a significant stock purchase by the company's CFO was disclosed. 

Shares of investment banking firm Jefferies Financial Group (NYSE:JEF) jumped 3.2% in the morning session after the company's recent third-quarter earnings beat market expectations. The report showed earnings per share of $1.01, which topped the consensus estimate of $0.69. This result suggested the potential for a rally in the company's shares. The positive sentiment was also supported by a broader trend in the banking sector. Data showed that many large U.S. banks set aside less money to cover potentially troubled loans in the third quarter compared to the previous quarter and the same period in the prior year.

Shares of computer processor maker AMD (NASDAQ:AMD) jumped 8.2% in the morning session after investors reacted to a series of highly bullish long-term financial targets and market projections unveiled by CEO Lisa Su at the company's Financial Analyst Day. 

Shares of digital financial services company SoFi Technologies (NASDAQ:SOFI) rose 1.3% in the morning session after the company announced the launch of SoFi Crypto, making it the first nationally chartered U.S. bank to offer direct cryptocurrency trading to consumers. 

Shares of smart security company Arlo (NYSE:ARLO) rose in the morning session after BWS Financial reiterated its "Buy" rating on the stock with a $26 price target, citing positive business developments. Analyst Hamed Khorsand highlighted the company's successful effort to clear out its old inventory. This move prepared the company for the release of over 100 new product stock-keeping units (SKUs), showing a proactive approach to innovation. This action was seen as key to keeping a leading position in the smart home security market.

Check out the companies making headlines yesterday:

Fast-food chain Arcos Dorados (NYSE:ARCO) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 5.2% year on year to $1.19 billion. Its GAAP profit of $0.71 per share was significantly above analysts’ consensus estimates.

Aerospace and defense company TransDigm (NYSE:TDG) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 11.5% year on year to $2.44 billion. On the other hand, the company’s full-year revenue guidance of $9.85 billion at the midpoint came in 1.1% below analysts’ estimates. Its non-GAAP profit of $10.82 per share was 7.6% above analysts’ consensus estimates.

Beauty and waxing service franchise European Wax Center (NASDAQ:EWCZ) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 2.2% year on year to $54.19 million. The company expects the full year’s revenue to be around $207 million, close to analysts’ estimates. Its GAAP profit of $0.09 per share was significantly above analysts’ consensus estimates.

Root’s third quarter results were met with a negative reaction from the market, despite the company delivering both revenue and earnings ahead of Wall Street expectations. Management attributed the quarter’s performance to rapid growth in both direct and partnership distribution channels, supported by the deployment of a new pricing algorithm and expansion into new states and marketing channels. CEO Alex Timm highlighted that these initiatives, along with advancements in pricing technology, drove a record number of policies in force and strong underwriting results. However, the drop in operating margin and rising competitive intensity were also emphasized as factors shaping the quarter’s outcome.

Fortrea’s third quarter results were met with a significant positive response from the market, as robust demand across its clinical pharmacology and clinical development businesses drove revenue growth. Management highlighted that win rates with biotech clients doubled compared to the prior quarter, and strong RFP volumes led to new business wins in both new and repeat clients. CEO Anshul Thakral credited operational improvements, noting, “Our win rates improved significantly, reaching the highest level in six quarters,” and emphasized the company’s ability to accelerate site selection and trial enrollment through technology and workflow enhancements.

PacBio’s third quarter was met with a significant negative market reaction, reflecting disappointment over revenue that fell short of Wall Street expectations. Management attributed the underperformance primarily to a slowdown in instrument shipments, especially Vega systems in Europe, and lower average selling prices for Revio systems. CEO Christian Henry highlighted that while instrument placements were weaker, consumable sales reached an all-time high, driven by growing adoption among clinical and commercial customers. Henry described the funding environment in the Americas as “challenging,” particularly for academic and government research customers, which lengthened procurement cycles and weighed on demand.

Cencora’s third quarter saw a positive market response, as the company delivered revenue and non-GAAP earnings that exceeded Wall Street expectations. Management pointed to strong growth in its U.S. Healthcare Solutions segment and the contribution of specialty pharmaceuticals as key drivers. CEO Robert Mauch emphasized that investments in areas like specialty distribution and recent acquisitions, such as Retina Consultants of America, enhanced the company’s value to both pharmaceutical manufacturers and healthcare providers. The segment’s operating income growth, driven by volume increases and higher-margin specialty products, was a highlight for the quarter.

HubSpot’s third quarter results were overshadowed by a notable market selloff, despite revenue and adjusted earnings coming in above Wall Street expectations. Management highlighted that customer growth was driven by ongoing platform consolidation, multi-hub adoption, and momentum among larger enterprise clients. CEO Yamini Rangan pointed to “years of product investment, strong partner alignment and rising brand awareness amongst upmarket decision-makers” as key contributors to growth. The quarter also saw significant traction from embedded AI features, with customers leveraging new marketing, sales, and data tools to improve performance outcomes.

Fastly’s third quarter was marked by strong revenue growth and robust operating leverage, as the company’s cross-sell and upsell strategies translated to notable gains across its product lines. Management credited disciplined execution and targeted investments in security enhancements and platform capabilities as primary drivers. CEO Kip Compton highlighted the success of multiproduct wins with strategic accounts and the expansion of Fastly’s security offerings, stating that these moves provided “exceptional performance, security, and operational efficiency.” The quarter also benefited from early bookings linearity and a focus on cost management, resulting in improved profitability and free cash flow.

Jazz Pharmaceuticals delivered a quarter that exceeded Wall Street’s expectations, with management attributing results to robust demand for Xywav and Epidiolex, as well as the swift and successful launch of Modeyso following its FDA approval. CEO Renée Galá highlighted the company’s execution, noting, "We delivered 2 FDA approvals that underscore Jazz's ability to bring highly differentiated therapies to patients with serious unmet needs." The quarter also saw positive developments in Jazz’s sleep and oncology franchises, reinforced by expanded guidelines and new data, which management believes will support continued growth.

U-Haul’s results for the third quarter reflected modest revenue growth but were notably impacted by higher depreciation expenses and losses on equipment sales, leading to a profit figure well below Wall Street expectations. Management pointed to increased costs associated with refreshing the truck fleet—an issue Chairman Edward Shoen highlighted, saying, “We reported this over two years ago that we were having to pay too much for trucks.” Despite these headwinds, the company continued to invest in expanding its dealer network and self-storage footprint, aiming to offset the operational drag from elevated vehicle costs.

Marqeta delivered a strong third quarter, with management attributing growth to accelerating payment volumes across a broad set of use cases, especially lending and Buy Now, Pay Later (BNPL) solutions. CEO and CFO Mike Milotich highlighted that total processing volume rose 33% year over year, fueled by both existing customers expanding into new geographies and the rapid adoption of flexible card credentials. The addition of new commercial programs and a significant acquisition in Europe further supported revenue and gross profit growth. Milotich noted, “This is our highest TPV growth rate since Q1 2024, despite the base we are growing over this quarter being almost 50% larger than the base we grew over in Q1 2024.”

Paycom’s third quarter results were met with a significant negative market reaction, as investors digested both the company’s in-line revenue performance and a slight miss on non-GAAP earnings per share. Management attributed the quarter’s outcomes to expanded automation through its new AI-driven IWant product and ongoing adoption of Beti, which together reduced service costs and improved operational efficiency. CEO Chad Richison emphasized the impact of these innovations on client engagement, particularly among C-suite users, noting, “IWant has already successfully responded to millions of queries…extending the power of our full solution automation.” The company also saw lower internal support volumes, reflecting efficiency gains from automation.

CONMED’s third quarter results were marked by steady revenue growth in both orthopedics and general surgery, supported by continued surgeon adoption of core products like BioBrace and the AirSeal platform. Management pointed to improvements in supply chain operations, especially within orthopedics, as a factor in supporting incremental sales growth. CEO Patrick Beyer credited “expanding clinical adoption and strong surgeon engagement” for BioBrace’s performance, while also highlighting operational progress in reducing back orders and improving service levels.

DigitalOcean’s third quarter results were met with a significant positive market reaction, reflecting strong execution and outperformance versus Wall Street expectations. Management credited the momentum to rapid growth among AI-native customers, an expanding base of high-spend digital enterprises, and increasing customer adoption of agentic cloud capabilities. CEO Padmanabhan Srinivasan highlighted that, “Demand for our agentic cloud has exceeded our supply,” citing the company’s ability to attract and retain larger customers as a notable achievement this quarter. The introduction of new features and a strategic focus on unified cloud offerings further contributed to the company’s robust top-line and margin expansion.

Energy Recovery’s third quarter results were met with a significant negative market reaction as investors digested both a year-over-year decline in revenue and a sharp drop in operating margin. Management attributed the downturn largely to lower mega-project shipments compared to last year and ongoing challenges in the commercialization of its CO2 refrigeration technology. CEO David Moon noted, “Mega-project shipments improved during the quarter and wastewater revenue continued to rebound,” but acknowledged that the company remains in the early stages of CO2 business development.

Watts Water's third quarter saw revenue and profit surpassing Wall Street expectations, yet the market responded negatively, reflecting concerns over near-term headwinds. Management pointed to strong organic growth in the Americas, driven by price increases and pull-forward demand ahead of tariff adjustments, while European performance showed early signs of stabilization. CEO Robert Pagano noted, “Organic sales increased 9% in the quarter, with favorable price in the Americas, volume and pull-forward demand more than offsetting the decline in Europe.” The company also benefited from recent acquisitions and favorable foreign exchange movements, but persistent uncertainty around tariffs and supply chain disruptions weighed on sentiment.

Amplitude’s third quarter results were well received by the market, delivering growth in both revenue and customer metrics. Management attributed this outcome to increasing demand from enterprise clients, strong adoption of multi-product offerings, and a series of recent AI-focused product launches. CEO Spenser Skates emphasized that the company’s platform is seeing “broad-based success with both AI natives and traditional enterprises,” underlining the shift toward larger, multi-year contracts and deeper product integration. Management also highlighted improvements in contract duration and recurring revenue as key contributors this quarter.

Encore Capital Group’s third quarter saw strong positive momentum, with revenue and profit surpassing Wall Street’s expectations and the stock responding with a significant gain. Management attributed the outperformance to record collections, particularly within its U.S. Midland Credit Management (MCM) business, supported by elevated portfolio purchases and advancements in digital and operational strategies. CEO Ashish Masih highlighted that these enhancements enabled Encore to reach more consumers and improve payment rates, stating, "The collections overperformance in the U.S. was driven by deployment of new technologies, enhanced digital capabilities and continued operational innovation."

DistributionNOW’s third quarter results reflected steady execution in a subdued energy market, with management attributing performance to disciplined cost control, operational leverage, and targeted customer focus. CEO David Cherechinsky noted the company’s “solutions-oriented approach” and highlighted growth in midstream and process solutions, along with efficient working capital management and improved inventory turns. Management acknowledged ongoing competitive pressure in core U.S. markets and cited customer consolidation as an industry headwind.

Installed Building Products delivered third-quarter results that exceeded Wall Street’s expectations, with management attributing the outperformance to a combination of the company’s national branch execution and strong growth in its heavy commercial segment. CEO Jeffrey Edwards emphasized that IBP’s extensive product and end-market diversity enabled it to navigate local market variability, while continued demand for commercial installations and complementary products helped counterbalance softness in residential new construction. Management also noted improved working capital management and disciplined capital returns as supporting factors behind the quarter’s performance.

Elanco's third quarter performance was marked by strong revenue growth across both pet and farm animal segments, with management highlighting U.S. Farm Animal up 20% and solid momentum in U.S. pet health. CEO Jeffrey Simmons attributed the results to the company’s expanding innovation portfolio, particularly new products like Credelio Quattro and Zenrelia. Despite these achievements and operational improvements, the market responded negatively, reflecting ongoing concerns about margin sustainability and competitive pressures. CFO Bob VanHimbergen noted that increased investments in global pet health launches contributed to operating expense growth, though these were partially offset by productivity gains and deleveraging efforts.

QuidelOrtho’s third quarter was marked by a positive market reaction, reflecting solid execution despite a year-on-year decline in reported sales. Management attributed the quarter’s underlying strength to sustained growth in core labs, immunohematology, and point-of-care product lines, excluding COVID and donor screening. CEO Brian Blaser emphasized, “We reported organic sales growth of 5%, excluding COVID sales and the U.S. donor screening business that we are in the process of exiting.” Margin improvement was driven by cost-saving initiatives and a disciplined commercial strategy, enabling the company to mitigate the impact of declining respiratory revenue.

The Pennant Group’s third quarter results were met with a negative market reaction despite revenue and adjusted EPS both surpassing Wall Street expectations. Management pointed to strong operational execution in home health, hospice, and senior living as key drivers, with CEO Brent Guerisoli highlighting that “new highs in revenue, census, occupancy and earnings” were achieved. However, investors weighed concerns about operating margin compression and the complexity of integrating a large acquisition, as the company prepares for further growth amid evolving industry dynamics.